Antiviral Program News Today

Or the rest of the world. With Earnings Seasons coming up and a few key Economic Data points later this month, how confident are you in the economic recovery . Great setink we had a of economic figures really since midmay through june when the reopening story was gaining the most momentum. Reports,o great jobs pmi, sales, housing data, all to the upside. Economic price indices we follow are in the u. S. Now at alltime highs. That being said, i think we may have a time of slowing in perhaps in th...

Here lea lets debate that today. Good to see everybody. Lets take you right to the boards and show you where we are trading. The dow is at 23 about 300 point gain S P Still Holding on the a 1 gain as is the nasdaq. Theres a russell at the far right hand side of your screen up just about 2 all right, jim, youre holding onto this cash we have come a long way from the bottom s p is up 26 . Nasdaq up 25 take stock of where we are and where you thip we may nk we may here taking stock of where we are,...

Really did the impossible by developing safe and effective coronavirus vaccines as quickly as they did. But then the government blew it. The government did not come up with any sort of National Plan at all to get the vaccines these scientists had made actually distributed at scale and administered to people with any sort of efficiency. And so even though those vaccines were developed and approved and produced with such alacrity all that got us is the situation were in tonight where millions of d...

Us live tonight in just a moment. Were also going to be joined live tonight by the man who president elect biden Just Announced will be in charge of the countrys Vaccination Efforts against covid19. Scientists and researchers, of course, did their part. They moved heaven and earth and really did the impossible by developing safe and effective coronavirus vaccines as quickly as they did. But then the government blew it. The government did not come up with any sort of National Plan at all to get t...

Hyundai Bioscience said Sunday that it will co-develop a broad-spectrum antiviral drug with the US National Institutes of Health, a federal agency for conducting and supporting medical research and the world’s largest public funder of biomedical research. A non-clinical evaluation agreement was signed on Friday between Hyundai Bioscience USA, a US-based subsidiary of the Korean pharmaceutical company, and the N...

Hyundai Bioscience said Sunday it will develop a broad-spectrum antiviral drug with the U.S. National Institutes of Health (NIH), a federal agency for conducting and supporting medical research.

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.

The consortium’s strategy is to create an AI-driven Structure-enabled Antiviral Platform (ASAP), using cutting-edge technology such as advanced structural biology, fragment screening, AI and machine learning, as well as computational chemistry on Folding@home, the world’s largest distributed computing platform to build a robust and open access antiviral discovery pipeline. Click to read more...

Washington: President Joe Biden s medical adviser Anthony Fauci warned that the US should be prepared for pretty bad flu season coupled with continu...

“If we had clinic-ready antivirals suitable for SARS-CoV-2 when the pandemic struck in late 2019, we could have perhaps saved millions of lives,” Ben Perry A bid to discover and develop accessible and affordable oral antivirals to combat outbreaks of COVID-19 and future pandemics has received an initial award of $68 million from the US National Institutes of Health (NIH) that will fund the first three-years of a five-year project to produce preclinical candidates against six ...